Holen Sie sich die Stockscreener-App
7.39
5.72%
0.40
Schlusskurs vom Vortag:
$6.99
Offen:
$6.94
24-Stunden-Volumen:
139.95K
Relative Volume:
1.42
Marktkapitalisierung:
$189.29M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.38M
KGV:
-5.2411
EPS:
-1.41
Netto-Cashflow:
$-15.54M
1W Leistung:
+15.83%
1M Leistung:
+21.75%
6M Leistung:
-18.07%
1J Leistung:
+49.29%
1-Tages-Spanne:
$6.8478
$7.41
1-Wochen-Bereich:
$6.39
$7.41
52-Wochen-Spanne:
$4.44
$11.52
Nuvectis Pharma Inc Stock (NVCT) Company Profile
Firmenname
Nuvectis Pharma Inc
Sektor
Branche
Telefon
360-837-7232
Adresse
1 BRIDGE PLAZA, SUITE 275, FORT LEE
Vergleichen Sie NVCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVCT
Nuvectis Pharma Inc
|
7.39 | 179.05M | 0 | -22.38M | -15.54M | -1.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-02 | Eingeleitet | Maxim Group | Buy |
| 2025-03-17 | Eingeleitet | Laidlaw | Buy |
| 2022-07-13 | Eingeleitet | Ladenburg Thalmann | Buy |
Nuvectis Pharma Inc Aktie (NVCT) Neueste Nachrichten
Nuvectis Pharma, Inc.'s (NASDAQ:NVCT) market cap rose US$18m last week; retail investors who hold 44% profited and so did insiders - Yahoo Finance
Nuvectis Pharma, Inc.'s (NASDAQ:NVCT) market cap rose US$18m last week; individual investors who hold 44% profited and so did insiders - simplywall.st
Technical Reactions to NVCT Trends in Macro Strategies - news.stocktradersdaily.com
Nuvectis Pharma (NASDAQ:NVCT) Trading 9.8% Higher – Here’s What Happened - Defense World
Nuvectis Pharma stock rating reiterated at Buy by H.C. Wainwright - Investing.com
Will Nuvectis Pharma Inc. stock attract more institutional investors2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
Is Nuvectis Pharma Inc a good long term investmentStock Price Forecasts & High Return Capital Gains - earlytimes.in
Will Nuvectis Pharma Inc. stock split attract more investors2025 Price Momentum & Scalable Portfolio Growth Ideas - Newser
Published on: 2025-11-30 11:27:46 - BỘ NỘI VỤ
Nuvectis Pharma to Host a Virtual Key Opinion Leader Meeting to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, Including the Combination with Osimertinib in NSCLC - marketscreener.com
Nuvectis Pharma to Host a Virtual Key Opinion Leader - GlobeNewswire
Nuvectis Pharma to Host Key Opinion Leader Meeting on NXP900 Phase 1b Program in Advanced Solid Tumors - Quiver Quantitative
Trading the Move, Not the Narrative: (NVCT) Edition - news.stocktradersdaily.com
How Nuvectis Pharma Inc. stock reacts to Fed rate cutsWeekly Profit Recap & Weekly Breakout Watchlists - newser.com
Nuvectis Pharma Inc. (NVCT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Nuvectis Pharma Inc. stock trendline breakdownPortfolio Risk Summary & Stock Market Timing Techniques - newser.com
How currency fluctuations impact Nuvectis Pharma Inc. stockEarnings Risk Summary & Weekly Watchlist for Consistent Profits - newser.com
What data driven models say about Nuvectis Pharma Inc.’s futureWeekly Gains Report & Reliable Volume Spike Trade Alerts - newser.com
Using RSI to spot recovery in Nuvectis Pharma Inc.Market Risk Report & Pattern Based Trade Signal System - newser.com
Predicting Nuvectis Pharma Inc. trend using moving averages2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
Top Analysts Predictions for Indobell Insulation Limited Stock Over 12 MonthsInsider Trading Activity & Free Unstoppable Trading Performance - earlytimes.in
What makes Nuvectis Pharma Inc. stock attractive to growth fundsMarket Volume Summary & Smart Investment Allocation Insights - newser.com
(NVCT) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Why Nuvectis Pharma Inc. stock remains undervaluedWeekly Market Outlook & Target Return Focused Stock Picks - newser.com
How Nuvectis Pharma Inc. stock performs in rate cut cycles2025 Market Sentiment & Stepwise Entry and Exit Trade Signals - newser.com
Director of Nuvectis Pharma Juan Sanchez Buys 20% More Shares - Yahoo Finance
Matthew Kaplan Acquires 11,000 Shares of Nuvectis Pharma (NASDAQ:NVCT) Stock - MarketBeat
Roth Capital Expects Lower Earnings for Nuvectis Pharma - Defense World
HC Wainwright Cuts Earnings Estimates for Nuvectis Pharma - Defense World
Nuvectis Pharma Executives Make Bold Moves with Major Stock Purchases! - TipRanks
Nuvectis Pharma director Sanchez buys $75k in NVCT stock By Investing.com - Investing.com Canada
Kaplan buys Nuvectis Pharma (NVCT) shares worth $64,240 By Investing.com - Investing.com South Africa
Insider Buying: Ron Bentsur Acquires Additional Shares of Nuvect - GuruFocus
Nuvectis Pharma director Sanchez buys $75k in NVCT stock - Investing.com
Kaplan buys Nuvectis Pharma (NVCT) shares worth $64,240 - Investing.com
Nuvectis Pharma chairman Bentsur buys $28,600 in shares By Investing.com - Investing.com Canada
Nuvectis Pharma chairman Bentsur buys $28,600 in shares - Investing.com
Finanzdaten der Nuvectis Pharma Inc-Aktie (NVCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):